- Home
- GSIW vs IMCC Comparison
GSIW vs IMCC Comparison
Compare GSIW & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- IMCC
- Stock Information
- Founded
- GSIW 2016
- IMCC 1980
- Country
- GSIW Hong Kong
- IMCC Israel
- Employees
- GSIW N/A
- IMCC N/A
- Industry
- GSIW
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- GSIW
- IMCC Health Care
- Exchange
- GSIW Nasdaq
- IMCC Nasdaq
- Market Cap
- GSIW 8.3M
- IMCC 7.5M
- IPO Year
- GSIW 2023
- IMCC N/A
- Fundamental
- Price
- GSIW $0.40
- IMCC $1.54
- Analyst Decision
- GSIW
- IMCC
- Analyst Count
- GSIW 0
- IMCC 0
- Target Price
- GSIW N/A
- IMCC N/A
- AVG Volume (30 Days)
- GSIW 65.7K
- IMCC 9.7K
- Earning Date
- GSIW 12-31-2024
- IMCC 05-07-2025
- Dividend Yield
- GSIW N/A
- IMCC N/A
- EPS Growth
- GSIW N/A
- IMCC N/A
- EPS
- GSIW N/A
- IMCC N/A
- Revenue
- GSIW $1,313,795.00
- IMCC $37,551,778.00
- Revenue This Year
- GSIW N/A
- IMCC $47.12
- Revenue Next Year
- GSIW N/A
- IMCC $12.83
- P/E Ratio
- GSIW N/A
- IMCC N/A
- Revenue Growth
- GSIW N/A
- IMCC 10.71
- 52 Week Low
- GSIW $0.35
- IMCC $1.29
- 52 Week High
- GSIW $12.30
- IMCC $7.86
- Technical
- Relative Strength Index (RSI)
- GSIW 43.18
- IMCC 47.55
- Support Level
- GSIW $0.35
- IMCC $1.29
- Resistance Level
- GSIW $0.41
- IMCC $1.56
- Average True Range (ATR)
- GSIW 0.04
- IMCC 0.14
- MACD
- GSIW 0.00
- IMCC 0.03
- Stochastic Oscillator
- GSIW 45.45
- IMCC 59.54
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.